Bellevue Life Sciences Acquisition (BLACW) Stock Price, News & Analysis

Company Overview

Bellevue Life Sciences Acquisition Corporation is a Delaware‐incorporated blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase or other similar business combination with one or more life sciences businesses. As a special purpose acquisition company (SPAC), it does not engage in operations other than identifying and completing a business combination with a target company in the biotechnology, pharmaceutical, diagnostic or medical technology sectors.

The company completed its initial public offering in late 2020, raising capital through the sale of its units, each of which included a common share and a warrant. Following its IPO, Bellevue Life Sciences Acquisition Corporation’s securities began trading on the Nasdaq under the ticker symbols “BLAC” for its common shares and “BLACW” for its warrants. The proceeds from the offering have been placed in a trust account pending the closing of a qualifying business combination.

Bellevue Life Sciences Acquisition Corporation is sponsored by Bellevue Asset Management, a Switzerland‐based investment manager with a dedicated focus on health care and life sciences. Leveraging Bellevue Asset Management’s deep sector expertise and network of industry relationships, the SPAC intends to target innovative companies in North America and Europe that are developing novel therapeutics, diagnostics or medical devices.

Key Stats

• Today's Range: $0.05 to $0.05
• 50-Day Range: $0.05 to $0.05
• 52-Week Range: $0.01 to $0.10
• Volume: N/A
• Average Volume: 55,965 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:BLACW
• CIK: 1840425
• Web: N/A
• Phone: 425-635-7700
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A